Literature DB >> 22990932

[Preliminary study on gastric tube esophagoplasty for corrosive strictures of the esophagus in children].

Wei Liu1, Jian-hua Liang, Jia-hang Zeng, Jue Tang.   

Abstract

OBJECTIVE: To study the clinical value of gastric tube esophagoplasty for complicated corrosive stricture of the esophagus in children.
METHODS: A retrospective analysis was performed to study 7 patients with complicated corrosive stricture of the esophagus who were treated with gastric tube esophagoplasty via retrosternal route between March 2010 and October 2011.
RESULTS: Three patients had a stricture longer than 2.5 cm, and 4 patients had more than one stricture. All the operations went well. The average time for mechanical ventilation postoperatively was 6 hours. No patients showed insufficient ventilation after withdraw of ventilator. There was 1 patient developed anastomotic leak which was healed a week later. One patient had anastomotic leak with pyloric obstruction, and the leak was healed 3 weeks after intraoperative placement of duodenal feeding tube and pyloric obstruction became patent 4 weeks later. There were 2 patients developed anastomotic stricture and they resumed normal diet after balloon dilatation. The average follow-up duration was 10.5 months. The quality of life was improved and no other complications were found.
CONCLUSION: Gastric tube esophagoplasty is a effective alternative for complicated corrosive stricture of the esophagus and the short-term outcomes are favorable.

Entities:  

Mesh:

Year:  2012        PMID: 22990932

Source DB:  PubMed          Journal:  Zhonghua Wei Chang Wai Ke Za Zhi        ISSN: 1671-0274


  1 in total

1.  Long-Term Outcomes of Caustic Esophageal Stricture with Endoscopic Balloon Dilatation in Chinese Children.

Authors:  Lan-Lan Geng; Cui-Ping Liang; Pei-Yu Chen; Qiang Wu; Min Yang; Hui-Wen Li; Zhao-Hui Xu; Lu Ren; Hong-Li Wang; Shunxian Cheng; Wan-Fu Xu; Yang Chen; Chao Zhang; Li-Ying Liu; Ding-You Li; Si-Tang Gong
Journal:  Gastroenterol Res Pract       Date:  2018-08-08       Impact factor: 2.260

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.